You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

ETHACRYNIC ACID - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ethacrynic acid and what is the scope of patent protection?

Ethacrynic acid is the generic ingredient in two branded drugs marketed by Bausch, Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Edenbridge Pharms, Hikma, Lupin Ltd, Par Pharm Inc, Sciegen Pharms Inc, and Upsher Smith Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for ethacrynic acid. Ten suppliers are listed for this compound.

Drug Prices for ETHACRYNIC ACID

See drug prices for ETHACRYNIC ACID

Recent Clinical Trials for ETHACRYNIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Neupharma SrlPhase 1
Centro Ricerche Cliniche di VeronaPhase 1
Sintesi Research SrlPhase 1

See all ETHACRYNIC ACID clinical trials

Pharmacology for ETHACRYNIC ACID
Drug ClassLoop Diuretic
Physiological EffectIncreased Diuresis at Loop of Henle
Medical Subject Heading (MeSH) Categories for ETHACRYNIC ACID

US Patents and Regulatory Information for ETHACRYNIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch EDECRIN ethacrynic acid TABLET;ORAL 016092-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Upsher Smith Labs ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 212417-001 Feb 19, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 213240-001 Oct 19, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal Pharms Co ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 208805-001 May 8, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211232-001 Aug 27, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.